Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E33.69 EPS (ttm)1.30 Insider Own0.30% Shs Outstand1.47B Perf Week-2.27%
Market Cap64.71B Forward P/E17.85 EPS next Y2.46 Insider Trans15.50% Shs Float1.47B Perf Month1.13%
Income1.95B PEG3.60 EPS next Q0.58 Inst Own73.90% Short Float4.76% Perf Quarter16.30%
Sales20.56B P/S3.15 EPS this Y53.50% Inst Trans4.29% Short Ratio6.99 Perf Half Y13.37%
Book/sh14.02 P/B3.13 EPS next Y11.82% ROA5.60% Target Price48.00 Perf Year2.93%
Cash/sh3.01 P/C14.58 EPS next 5Y9.36% ROE10.90% 52W Range35.56 - 45.79 Perf YTD-0.42%
Dividend1.04 P/FCF320.34 EPS past 5Y-10.30% ROI7.70% 52W High-4.13% Beta1.12
Dividend %2.37% Quick Ratio1.20 Sales past 5Y-10.30% Gross Margin56.90% 52W Low23.45% ATR0.57
Employees74000 Current Ratio1.50 Sales Q/Q3.20% Oper. Margin14.00% RSI (14)54.35 Volatility1.34% 1.26%
OptionableYes Debt/Eq0.41 EPS Q/Q-22.60% Profit Margin11.10% Rel Volume0.74 Prev Close44.17
ShortableYes LT Debt/Eq0.29 EarningsJul 20 BMO Payout66.50% Avg Volume9.97M Price43.90
Recom1.90 SMA20-1.83% SMA504.95% SMA2007.00% Volume7,401,381 Change-0.61%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Aug-22-16 11:46AM  Pfizer spends $14B on Medivation in cancer fight
10:55AM  This High-Quality Dividend Stock Belongs in Your Portfolio Now
07:52AM  Edwards Lifesciences Is Taking The Surgery Out Of Heart Surgery
06:21AM  What Do Analysts Recommend for Medtronic before Its 1Q17 Results?
Aug-18-16 04:30PM  How BSX Plans to Accelerate Its Neuromodulation Market Position
04:05PM  John Rogers Comments on Abbott Laboratories
Aug-17-16 05:05PM  Understanding Sanofis Growth Drivers in 2Q16
01:14PM  10 value stocks that have become more attractive in the past year at MarketWatch
Aug-15-16 05:34PM  Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
05:22PM  The 10 Best Dividend Aristocrats
10:15AM  Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Aug-11-16 01:08PM  Abbott Labs Salesman Commits Suicide, Cites Company Pressure To Hit Sales Targets
Aug-10-16 01:04PM  ABBOTT LABORATORIES Financials
11:04AM  What Analysts Recommend for Becton Dickinson after 3Q16 Earnings
10:47AM  Abbott Laboratories (ABT) Stock Declines, Alere Deal Looks Uncertain
08:30AM  Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations CNW Group
Aug-09-16 11:06AM  Becton Dickinsons BD Life Sciences in Fiscal 3Q16: Strong Growth
09:06AM  Becton Dickinsons BD Medical Segment Sales in Fiscal 3Q16
Aug-08-16 04:59PM  Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients
02:35PM  Analyst: Abbott probably cant back out of its $5.8B offer to buy Alere at bizjournals.com
09:43AM  Alere Files Delayed 2015 Results, Fight With Abbott Goes On at Bloomberg
12:09AM  Mara Abbotts Beautiful Ride in Rio at The Wall Street Journal
Aug-03-16 04:35PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report
12:06PM  Insiders Love These 5 Stocks Right Now
Aug-02-16 10:00AM  Abbott Unveils Alinity, its Unified Family of Innovative Next-Generation Diagnostics Systems PR Newswire
Aug-01-16 09:09AM  Boston Scientifics Updated Guidance for 2016
01:57AM  Weekly CEO Buys: Abbott Laboratories, GE, OPKO Health
Jul-29-16 12:58PM  Boston Scientifics Stock Surged after 2Q16 Earnings
09:45AM  The C-Suite Speaks: Animal Spirits
Jul-28-16 04:37PM  Abbott stock up 1.8% after chief executive officer's $45 mln share buy at MarketWatch
02:26PM  Why Alere Inc. Climbed 21% Today at Motley Fool
02:19PM  Bulls are following uptrend in Abbott Labs
12:48PM  Oracle buying Netsuite for $9.3 billion cash
11:26AM  Alere loses $1B of value in 20 minutes after reports of new federal subpoena at bizjournals.com
09:40AM  Faber Report: Alere shares soar
12:11AM  Alere Faces Criminal Probe Over Medicare, Medicaid Billing at The Wall Street Journal
Jul-27-16 08:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $777,216 of Stocks
08:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $7.8 million of Stocks
08:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $7.6 million of Stocks
08:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $45.5 Million of Stocks
08:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $10.5 million of Stocks
05:10PM  Diagnostic tester Alere plunges on reports of second front in criminal probe at CNBC
05:00PM  Alere shares plummet after feds launch criminal probe into billing at MarketWatch
04:57PM  Abbott CEO Spends $45.5 Million to Boost Personal Stock Holdings at Bloomberg
04:41PM  Alere faces criminal probe over Medicare, Medicaid Billing - WSJ
04:17PM  Alere (ALR) Stock Plunged on Criminal Probe, CNBC's DeAngelis Says
04:00PM  Alere Plunges by Record on Report of U.S. Criminal Probe at Bloomberg
10:26AM  Top 10 Dividend Aristocrats to Buy at a Discount Now
Jul-26-16 04:29PM  Will BDX Beat Revenue Estimates in Fiscal 3Q16?
11:04AM  Whats Johnson & Johnsons Guidance for 2016?
09:04AM  What Key Developments Did JNJ Announce in 2Q16?
Jul-25-16 02:20PM  Massachusetts class-action lawsuit filed over Alere's blood test at bizjournals.com
09:06AM  Abbott Laboratories Avoids a Sell Rating from Analysts
05:47AM  The Economy, Interest Rates, Earnings and the Markets
Jul-22-16 02:15PM  New Research Reports on NFLX, AXP, GM & Others
01:14PM  How Did Johnson & Johnsons Segments Perform in 2Q16?
10:21AM  Animal Spirits Have Returned
08:55AM  Did Hedge Funds Anticipate These M&A Deals? at Insider Monkey
07:29AM  R&D Investments, Product Launches Key to Abbotts 2Q Performance
07:29AM  Abbotts 2Q16 Earnings Propelled by Impressive Sales Growth
Jul-21-16 10:39AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016
09:26AM  Abbott Labs (ABT) Stock Price Target Raised at Barclays
08:40AM  Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science
08:00AM  How Abbvie's Humira Undercuts The Drug Industry Price Defense at Forbes
Jul-20-16 03:59PM  Pisani's market close: Big earnings today
03:33PM  Abbott (ABT) Beats on Earnings & Sales in Q2, Maintains View
03:06PM  [$$] Abbott Labs Profit Tops Views at The Wall Street Journal
02:52PM  US STOCKS-Microsoft propels Wall Street to new record highs Reuters
12:56PM  How Investors Reacted to The Latest Earnings Reports of These Companies at Insider Monkey
12:55PM  Abbott's Alere Deal Continues To Face Uncertainty
12:44PM  Edited Transcript of ABT earnings conference call or presentation 20-Jul-16 1:00pm GMT
10:40AM  [$$] St. Jude Medical Logs Double-Digit Sales Growth at The Wall Street Journal
09:31AM  St. Jude Medical Up Slightly as It Meets Estimates
09:26AM  Abbott sales beat on higher demand for medical devices
09:05AM  Abbott Labs (ABT) Stock Rising on Q2 Earnings Beat
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:32AM  Investors Greet Abbott Q2 Earnings Number
08:32AM  Abbott (ABT) Beats on Earnings & Sales in Q2
08:26AM  Morning Movers: Morgan Stanley Jumps on Earnings; Valeant Pharmaceuticals Climbs on Drug Approval at Barrons.com
08:02AM  Abbott tops Street 2Q forecasts
07:59AM  Abbott Quarterly Earnings Beat Expectations on Device Sales at Bloomberg
07:57AM  Abbott Labs reports 3.2 percent rise in sales
07:52AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:45AM  Abbott Reports Second-Quarter 2016 Results PR Newswire
07:07AM  Q2 2016 Abbott Laboratories Earnings Release - Before Market Open
Jul-19-16 07:47PM  Will the Strong Dollar Hurt Abbott's Q2 Earnings? at Investopedia
03:35PM  Abbott Labs (ABT) Stock Falling Ahead of Q2 Earnings Report
02:45PM  St. Jude Medical (STJ) Stock Lower Ahead of Q2 Results
11:52AM  ETFs with exposure to Abbott Laboratories : July 19, 2016
10:06AM  Medical Stocks to Post Earnings This Week: ABT, BIIB, ALIOF
08:58AM  How to Profit From Abbott Labs
08:07AM  5 Big Medtech Stocks Investors Love Right Now -- but Should You Buy Them?
Jul-18-16 05:05PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
01:53PM  What to Look for When Abbott Labs (ABT) Reports Q2 Earnings
12:07PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
12:05PM  Abbott Laboratoriess Valuation before Its 2Q16 Results
10:06AM  What to Expect from Abbott Laboratoriess Earnings in 2Q16
09:37AM  Abbott Labs (ABT) Q2 Earnings: Will the Stock Surprise?
09:05AM  A Look at Johnson & Johnsons Valuation ahead of Its 2Q16 Results
08:30AM  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea CNW Group
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM